PHAR logo

PHAR
Pharming Group

962
Mkt Cap
$1.2B
Volume
2,114.00
52W High
$21.34
52W Low
$8.60
PE Ratio
472.98
PHAR Fundamentals
Price
$16.98
Prev Close
$16.53
Open
$16.85
50D MA
$16.40
Beta
0.50
Avg. Volume
10,993.03
EPS (Annual)
$0.0415
P/B
4.30
$1,255.63
Loading...
Loading...
News
all
press releases
Pharming Group (PHAR) Expected to Announce Quarterly Earnings on Thursday
Pharming Group (NASDAQ:PHAR) will be releasing its Q1 2026 earnings before the market opens on Thursday, May 7. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2026-5-7-pharming-group-stock...
MarketBeat·2d ago
News Placeholder
More News
News Placeholder
Pharming Group (PHGUF) to Release Quarterly Earnings on Thursday
Pharming Group (OTCMKTS:PHGUF) will be releasing earnings before the market opens on Thursday, May 7. (View Earnings Report at...
MarketBeat·2d ago
News Placeholder
Pharming Group N.V. Sponsored ADR (NASDAQ:PHAR) Sees Significant Decline in Short Interest
Pharming Group N.V. Sponsored ADR (NASDAQ:PHAR - Get Free Report) was the target of a large decline in short interest in the month of April. As of April 15th, there was short interest totaling 9,179...
MarketBeat·4d ago
News Placeholder
Pharming Group N.V. Sponsored ADR (NASDAQ:PHAR) Sees Large Decline in Short Interest
Pharming Group N.V. Sponsored ADR (NASDAQ:PHAR - Get Free Report) was the recipient of a significant drop in short interest in March. As of March 31st, there was short interest totaling 12,882...
MarketBeat·14d ago
News Placeholder
Pharming Group (NASDAQ:PHAR) Sees Large Volume Increase - Here's What Happened
Pharming Group (NASDAQ:PHAR) Sees Strong Trading Volume - What's Next...
MarketBeat·19d ago
News Placeholder
Pharming Group (OTCMKTS:PHGUF) Shares Gap Up - Should You Buy?
Pharming Group (OTCMKTS:PHGUF) Shares Gap Up - Still a Buy...
MarketBeat·22d ago
News Placeholder
Pharming Group N.V. Sponsored ADR (NASDAQ:PHAR) Receives Average Recommendation of "Hold" from Brokerages
Pharming Group N.V. Sponsored ADR (NASDAQ:PHAR - Get Free Report) has been given an average recommendation of "Hold" by the five analysts that are presently covering the firm, Marketbeat.com reports...
MarketBeat·22d ago
News Placeholder
Pharming Group (NASDAQ:PHAR) Coverage Initiated at Canaccord Genuity Group
Canaccord Genuity Group began coverage on Pharming Group in a research report on Friday. They set a "buy" rating and a $37.00 price target for the company...
MarketBeat·22d ago
News Placeholder
Pharming Group N.V. Sponsored ADR (NASDAQ:PHAR) Short Interest Up 33.9% in March
Pharming Group N.V. Sponsored ADR (NASDAQ:PHAR - Get Free Report) was the target of a significant increase in short interest in the month of March. As of March 13th, there was short interest totaling...
MarketBeat·1mo ago
News Placeholder
HC Wainwright Reaffirms "Buy" Rating for Pharming Group (NASDAQ:PHAR)
HC Wainwright reaffirmed a "buy" rating and issued a $37.00 price target on shares of Pharming Group in a research note on Tuesday...
MarketBeat·1mo ago
<
1
2
...
>

Latest PHAR News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.